Filing Details

Accession Number:
0001144204-18-063432
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-06 19:00:28
Reporting Period:
2018-12-03
Accepted Time:
2018-12-06 19:00:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc. ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635111 Lisa Bright C/O Intercept Pharmaceuticals, Inc.
10 Hudson Yards, Floor 37
New York NY 10001
President, International No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 3,800 $111.23 22,488 No 4 S Direct
Common Stock Disposition 2018-12-03 700 $112.12 21,788 No 4 S Direct
Common Stock Disposition 2018-12-03 200 $113.22 21,588 No 4 S Direct
Common Stock Disposition 2018-12-04 300 $111.00 21,288 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.00 to $112.48, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.00 to $113.44, inclusive.